Author Question: Recalling that iron lies at the lowest point of the nuclear energy curve, which of the following ... (Read 20 times)

Engineer

  • Hero Member
  • *****
  • Posts: 527
Recalling that iron lies at the lowest point of the nuclear energy curve, which of the following nuclear reactions would release that is, convert to other forms nuclear energy from iron?
 
  A) Fusion
  B) Fission
  C) Both of the above.
  D) None of the above.
  E) This is the wrong answer.

Question 2

Two square air-filled parallel plates that are initially uncharged are separated by 1.2 mm, and each of them has an area of 190 mm2.
 
  How much charge must be transferred from one plate to the other if 1.1 nJ of energy are to be stored in the plates? (00 = 8.85  10-12 C2/N  m2)
  A) 56 pC
  B) 39 pC
  C) 78 pC
  D) 3.5 C



mceravolo

  • Sr. Member
  • ****
  • Posts: 349
Answer to Question 1

D

Answer to Question 2

A



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Approximately 25% of all reported medication errors result from some kind of name confusion.

Did you know?

Over time, chronic hepatitis B virus and hepatitis C virus infections can progress to advanced liver disease, liver failure, and hepatocellular carcinoma. Unlike other forms, more than 80% of hepatitis C infections become chronic and lead to liver disease. When combined with hepatitis B, hepatitis C now accounts for 75% percent of all cases of liver disease around the world. Liver failure caused by hepatitis C is now leading cause of liver transplants in the United States.

Did you know?

The most destructive flu epidemic of all times in recorded history occurred in 1918, with approximately 20 million deaths worldwide.

Did you know?

Since 1988, the CDC has reported a 99% reduction in bacterial meningitis caused by Haemophilus influenzae, due to the introduction of the vaccine against it.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library